These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32989)

  • 1. [Hepatoprotective effect of a combination of UDPG, vitamin B 12 and liver extract in psychiatric patients with liver diseases].
    Castellani A; Colafelice M; Fichera M
    Clin Ter; 1978 Sep; 86(6):567-76. PubMed ID: 32989
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of different liver-protective substances in the course of antitubercular chemotherapy and their effectiveness in preventing and countering the appearance of metabolic and functional liver changes Clinico-statistical studies].
    Natale F; Perna G
    Arch Sci Med (Torino); 1979; 136(4):591-6. PubMed ID: 550759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of UDPG, glutathione and vitamin B 12 therapy on various liver function indices in patients with liver cirrhosis].
    Coltorti M
    Clin Ter; 1975 Feb; 72(4):323-35. PubMed ID: 1222512
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the changes in some laboratory parameters in liver disease patients treated with Toxepasi Complex].
    Lenzi S
    Minerva Med; 1976 Sep; 67(46):2961-74. PubMed ID: 967362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-statistical study of medical treatment of hyperazotemic syndromes of prevalently dysmetabolic origin].
    Taglioretti D
    Minerva Urol; 1975; 27(3):127-31. PubMed ID: 1143239
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of a new hepatoprotective drug on bilirubinemia in geriatric age patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):789-92. PubMed ID: 5740954
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cholesterolemic changes after treatment with a new hepatoprotective drug in geriatric patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):785-7. PubMed ID: 5740953
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic trial of uridine diphosphoglucose (UDPG) in physiological hyperbilirubinemia in newborn infants].
    Salazar De Sousa J; Sanches N; Pages MV
    Minerva Pediatr; 1975 Jun; 27(20):1162-5. PubMed ID: 1134472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of UDPG on the surgical patient].
    Girotto T; Tinti S; Padovani G
    Minerva Anestesiol; 1975 Apr; 41(4):194-202. PubMed ID: 1186979
    [No Abstract]   [Full Text] [Related]  

  • 10. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis].
    Ravazzoni C; Balzano E; Cuneo S
    Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of UDPG in the treatment of porphyria cutanea tarda. Preliminary findings].
    Okolicsanyi L; Orlando R; Busnardo F; Naccarato R; Veller-Fornasa C; Polin R
    Clin Ter; 1980 Sep; 94(6):687-94. PubMed ID: 7460503
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the use of liver extracts enriched with uridine, cytidine and vitamin B 12 in pediatric therapy].
    Rizzo A
    Minerva Pediatr; 1971 May; 23(18):803-10. PubMed ID: 5090393
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical studies of the effect of a phosphorylated glycoderivative in acute viral hepatitis].
    Fiori GP; Mazza L
    Minerva Med; 1976 Mar; 67(12):132-40. PubMed ID: 1256689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of bilirubin kinetics in a case of Dubin-Johnson syndrome before and after treatment with UDPG].
    Orlando R; Caregaro L; Muggeo M; Ghidini O; Okolicsanyi L
    Clin Ter; 1976 Feb; 76(4-3):323-32. PubMed ID: 971583
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic afficacy of UDPG in non-hemolytic familial jaundice: metabolic studies in a patient with Dubin-Johnson syndrome. II].
    Cortellazzo S; Orlando R; Ortolani C; Brun GD; Okolicsànyi L
    Clin Ter; 1976 Jun; 77(5):459-72. PubMed ID: 1009747
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases].
    Grimaldi N; Santoro C
    Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlled clinico-statistical studies on the role of the nucleosides in an association of hepatoprotective and anti-asthenic action].
    Soranzo ML
    Minerva Med; 1974 Feb; 65(8):391-7. PubMed ID: 4820721
    [No Abstract]   [Full Text] [Related]  

  • 18. [Uridine diphosphate glucose in acute viral hepatitis].
    Crispo C; Perruna F; Di Nicuolo G; Rosiello A
    Minerva Med; 1982 Feb; 73(5):187-90. PubMed ID: 7038553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nucleosides in the therapy of hepatopathies].
    Urbinati GC
    Clin Ter; 1966 Oct; 39(1):39-54. PubMed ID: 5998856
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical work on a new drug combination used in liver diseases and its consequences].
    Naufal J
    Hospital (Rio J); 1969 Apr; 75(4):1469-82. PubMed ID: 5306437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.